Duexis is supposed to control upper GI bleeding, but hasn't gotten the red out of HZNP's stock price yet. Finally a positive article today. With $120M in the bank and 2 products launching, you would think this is a "no brainer."
Duexis can stop the bleeding, and Rayos can stop the pain. HZNP and its partners need to execute now. Although I get pistol whipped every day by the decline in stock price, I have to remain optimistic that the major players and insiders are buying this stock. If anything, they don't care in the short term if the price goes down - more and cheaper shares to be bought up.
Will be interesting to see how many new shorts there are (end of Sep numbers should be out "shortly."
Brittish and European approvals approvals should be out any time now (exepcted 2nd half 2012). Stars are line up the right way for HZNP - just need to get some positive news momentum to regain small investor confidence.
Happy for the positive news but what a joke Motley Fool is! 2 days ago they bash, today they praise HZNP. FYI.. as of 9AM this morning 1.6 short shares were available (to short). This is down from like 60,000 recently. That means the Shorts are no longer so confident. HZNP is a buy now and its also a long play going fwd. If better than expected results are reported for Q3 it will continue to rise and if Q4 results are also positive it will get back to $5 - $6 in Feb, IMO.